188 related articles for article (PubMed ID: 10575313)
1. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.
Ballen KK; Becker P; Levebvre K; Emmons R; Lee K; Levy W; Stewart FM; Quesenberry P; Lowry P
Oncology; 1999 Nov; 57(4):287-92. PubMed ID: 10575313
[TBL] [Abstract][Full Text] [Related]
2. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
Shepherd JD; Pringle LE; Barnett MJ; Klingemann HG; Reece DE; Phillips GL
J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
[TBL] [Abstract][Full Text] [Related]
3. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.
Vose JM; Reed EC; Pippert GC; Anderson JR; Bierman PJ; Kessinger A; Spinolo J; Armitage JO
J Clin Oncol; 1993 Jul; 11(7):1306-10. PubMed ID: 8315426
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support.
Meisenberg B; Lassiter M; Hussein A; Ross M; Vredenburgh JJ; Peters WP
Bone Marrow Transplant; 1994 Aug; 14(2):287-91. PubMed ID: 7994244
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults.
Kohno A; Takeyama K; Narabayashi M; Tamayose K; Watanabe T; Adachi I; Tobisu K; Tobinai K; Shimoyama M
Jpn J Clin Oncol; 1993 Feb; 23(1):46-52. PubMed ID: 8459641
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation.
Laszlo D; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Lombardini L; Longo G; Fanci R; Azzi A; De Santis R
Haematologica; 1995; 80(5):421-5. PubMed ID: 8566882
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.
Turkeri LN; Lum LG; Uberti JP; Abella E; Momin F; Karanes C; Sensenbrenner LL; Haas GP
J Urol; 1995 Mar; 153(3 Pt 1):637-40. PubMed ID: 7861502
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic cystitis complicating bone marrow transplantation.
Letendre L; Hoagland HC; Gertz MA
Mayo Clin Proc; 1992 Feb; 67(2):128-30. PubMed ID: 1545575
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the benefits of sodium 2-mercaptoethane sulfonate (MESNA) therapy for children undergoing high-dose chemotherapy].
Sato J; Takaue Y; Saito S; Okamoto Y; Hirao A; Shimizu T; Abe T; Watanabe T; Kawano Y; Ninomiya T
Rinsho Ketsueki; 1993 Jan; 34(1):7-12. PubMed ID: 8450612
[TBL] [Abstract][Full Text] [Related]
10. [Hemorrhagic cystitis related to the high-dose conditioning therapy in a bone marrow recipient].
Machaczka M; Rucińska M; Piatkowska-Jakubas B; Załuska A; Skotnicki AB
Przegl Lek; 2001; 58(1):51-3. PubMed ID: 11450158
[TBL] [Abstract][Full Text] [Related]
11. Preventive measures for cyclophosphamide-related hemorrhagic cystitis in blood and bone marrow transplantation: an Italian multicenter retrospective study.
Gonella S; di Pasquale T; Palese A
Clin J Oncol Nurs; 2015 Feb; 19(1):E8-E14. PubMed ID: 25689665
[TBL] [Abstract][Full Text] [Related]
12. National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants.
Nicolau DP; Hogan KR
Mayo Clin Proc; 1992 Jun; 67(6):611-2. PubMed ID: 1434892
[No Abstract] [Full Text] [Related]
13. [Hemorrhagic cystitis after high dose chemotherapy. An interdisciplinary problem].
Sommerkamp H
Urologe A; 1998 Sep; 37(5):516-21. PubMed ID: 9796033
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
[TBL] [Abstract][Full Text] [Related]
15. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.
Bedi A; Miller CB; Hanson JL; Goodman S; Ambinder RF; Charache P; Arthur RR; Jones RJ
J Clin Oncol; 1995 May; 13(5):1103-9. PubMed ID: 7738616
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome.
Brugieres L; Hartmann O; Travagli JP; Benhamou E; Pico JL; Valteau D; Kalifa C; Patte C; Flamant F; Lemerle J
J Clin Oncol; 1989 Feb; 7(2):194-9. PubMed ID: 2644398
[TBL] [Abstract][Full Text] [Related]
17. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
Hows JM; Mehta A; Ward L; Woods K; Perez R; Gordon MY; Gordon-Smith EC
Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
[TBL] [Abstract][Full Text] [Related]
19. [The prevention of hemorrhagic cystitis during the performance of bone marrow and peripheral blood stem cell transplantation in the hematologic cancer clinic].
Uss AL; Milanovich NF; Snegir' VM; Zmachinskiĭ VA; Skriagin AE
Ter Arkh; 1996; 68(10):49-52. PubMed ID: 9026944
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy.
Haselberger MB; Schwinghammer TL
Ann Pharmacother; 1995 Sep; 29(9):918-21. PubMed ID: 8547741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
